Shares in the pharma and automotive sectors were among those that fit the bill. Fund managers lapped up pharma given the recent underperformance, lower input prices and attractive valuations. With first-quarter results encouraging, they bought into stocks like Dr Reddy’s Laboratories, Aurobindo Pharma, and Suven Pharmaceuticals.
Subscribe To Our Free Newsletter |